A Study of CDX-1307, in Patients With Incurable Breast, Colorectal, Pancreatic, Ovarian or Bladder Cancer (CDX 1307-01)

Clinical trial NCT00709462 · COMPLETED

Trial details

NCT number: NCT00709462
Sponsor: Celldex Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Cancer Colorectal Cancer Pancreatic Cancer Bladder Cancer Ovarian Cancer

Start date: 2004-03-01
Primary completion: 2010-05-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.